Robert Marcec

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 18

Top Topics

Coronavirus Disease

Medical Students

Top Venues

Postgraduate medical journal

Rheumatology international

British journal of clinical pharmacology

JMIR bioinformatics and biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Robert Marcec, Robert Likić
Using Twitter for sentiment analysis towards AstraZeneca/Oxford, Pfizer/BioNTech and Moderna COVID-19 vaccines. Postgraduate medical journal 98 (1161) (2023)
Elena Primorac Padjen, Robert Marcec, Matija Zidar, Ivan Padjen, Tomislav Katanec, Branimir Anić, Robert Likić
Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data. Rheumatology international 44 (2) (2023)
Elena Primorac Padjen, Robert Marcec, Matija Zidar, Ivan Padjen, Tomislav Katanec, Branimir Anić, Robert Likić
Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data. Rheumatology international 44 (2) (2023)
Robert Marcec, Fran Posavec, Robert Likić
Vitamin C utilisation in 2020: have we bought a lemon? Postgraduate medical journal 98 (1163) (2023)
Elena Primorac Padjen, Robert Marcec, Matija Zidar, Ivan Padjen, Tomislav Katanec, Branimir Anić, Robert Likić
Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data. Rheumatology international 44 (2) (2023)
Robert Marcec, Laura Alexandra Seils, Ana Isabel Gonzalez, Katarzyna Dubas-Jakóbczyk, Alicja Domagała, Sorin-Adrian Dan, Linda E Flinterman, Robert Likić, Ronald Batenburg
Tackling medical deserts: unearthing factors that influence medical students' attitudes and the path forward. Postgraduate medical journal (2023)
Elena Primorac Padjen, Robert Marcec, Matija Zidar, Ivan Padjen, Tomislav Katanec, Branimir Anić, Robert Likić
Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data. Rheumatology international (2023)
Robert Marcec, Vinko Michael Dodig, Igor Radanovic, Robert Likić
Intravenous immunoglobulin (IVIg) therapy in hospitalised adult COVID-19 patients: A systematic review and meta-analysis. Reviews in medical virology 32 (6) (2022)
Robert Marcec, Josip Stjepanovic, Robert Likić
Seasonality of Hashimoto Thyroiditis: Infodemiology Study of Google Trends Data. JMIR bioinformatics and biotechnology 3 (1) (2022)
Robert Marcec, Robert Likić
Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients? Clinical pharmacokinetics 61 (9) (2022)
Robert Marcec, Fran Posavec, Robert Likić
Vitamin C utilisation in 2020: have we bought a lemon? Postgraduate medical journal (2022)
Robert Marcec, Matea Majta, Robert Likić
Brave, new and divided post-COVID-19 world. Postgraduate medical journal 98 (e2) (2022)
Robert Marcec, Josip Stjepanovic, Robert Likić
Seasonality of Hashimoto Thyroiditis: Infodemiology Study of Google Trends Data. JMIR bioinformatics and biotechnology 3 (1) (2022)
Robert Marcec, Robert Likić
Using Twitter for sentiment analysis towards AstraZeneca/Oxford, Pfizer/BioNTech and Moderna COVID-19 vaccines. Postgraduate medical journal (2021)
Robert Marcec, Robert Likić
Postvaccination anaphylaxis and mRNA-based SARS-CoV-2 vaccines-Much ado about nothing? British journal of clinical pharmacology 87 (9) (2021)
Martina Calusic, Robert Marcec, Lea Luksa, Ivan Jurkovic, Natasa Kovac, Slobodan Mihaljevic, Robert Likić
Safety and efficacy of fluvoxamine in COVID-19 ICU patients: An open label, prospective cohort trial with matched controls. British journal of clinical pharmacology (2021)
Robert Marcec, Matea Majta, Robert Likić
Brave, new and divided post-COVID-19 world. Postgraduate medical journal (2020)
Robert Marcec, Matea Majta, Robert Likić
Will vaccination refusal prolong the war on SARS-CoV-2? Postgraduate medical journal 97 (1145) (2020)